Dissolving Peptide Strips: Film Chemistry and What the Label Should State

Research-use-only context. This article summarizes published third-party scientific literature and laboratory practice. It is not medical advice, not a therapeutic or performance claim, and not a usage guide. US Prime Peptides products are supplied strictly for in vitro laboratory research and are not for human or veterinary use.

This article explains what a dissolving peptide strip is as a piece of pharmaceutical technology: the polymer film, the plasticizer, how the film is cast and dried, why "mass per strip" is a statistical claim that needs a content uniformity test, and what the label and certificate should state. It is a formulation and documentation reference, not a usage guide.

What an orodispersible film is

A dissolving strip is an orodispersible film, abbreviated ODF: a thin, flexible sheet of water-soluble polymer, a few square centimeters in area and well under a millimeter thick, in which an active ingredient is dispersed or dissolved. The European Medicines Agency fixed the term, and Hoffmann, Breitenbach, and Breitkreutz's 2011 review in Expert Opinion on Drug Delivery traces how the technology moved from breath-freshener strips to regulated products.

By mass, a strip is mostly polymer. The film former is usually a cellulose ether such as hypromellose (HPMC) or hydroxypropylcellulose (HPC), or a polysaccharide such as pullulan, sodium alginate, or maltodextrin, or polyvinyl alcohol. Borges and colleagues' 2015 review in Journal of Controlled Release is organized around those polymer matrices and the properties each gives the film: tensile strength, flexibility, dissolution rate in water, and water uptake.

A plasticizer, most often glycerol, propylene glycol, or a low-molecular-weight polyethylene glycol, is added at a few percent to keep the dried film from cracking. Taste-masking agents, colorants, and sometimes a surfactant make up the remainder. Dixit and Puthli's 2009 review in the same journal lists the material classes and the critical manufacturing variables.

How films are cast and why the process matters

Most films are made by solvent casting: the polymer, plasticizer, and active are dissolved or dispersed in water or a water-ethanol mixture, the viscous solution is spread at a fixed gap onto a release liner, the sheet is dried, and the dried sheet is cut into strips. Every one of those steps leaves a mark on the finished strip's documentation.

The casting gap and the solution viscosity set film thickness, and thickness sets mass per strip. Visser and colleagues' 2015 paper in International Journal of Pharmaceutics developed a general casting solution of hypromellose, carbomer, glycerol, disodium EDTA, and trometamol and showed that adding water-soluble actives changed the solution's viscosity and, with it, the film's mechanical properties and disintegration time. The active is not a passive passenger in the matrix.

Drying is the step that stresses a peptide. The wet film is heated to drive off water, which exposes the active to elevated temperature while it is still in a mobile aqueous environment. Gil and colleagues reported in a 2023 International Journal of Pharmaceutics study that desmopressin acetate, a nonapeptide, degraded under the heat of film manufacture, and that xanthan gum in the film reduced total impurities over six months under accelerated conditions. The lesson for a peptide strip certificate is that related substances should be reported at release, not assumed from the raw material.

Multi-active films raise a further process question. Thabet, Lunter, and Breitkreutz produced double- and triple-layer films by continuous casting in a 2018 European Journal of Pharmaceutical Sciences paper and used confocal Raman microscopy to show that the two actives migrated between layers shortly after manufacture. For a strip that carries two peptides, the certificate should report each by its own identity and assay, whether or not the film was built in layers.

Content uniformity: why "per strip" is a statistical claim

A label that states a mass per strip is making the same promise about every strip in the pack, so the certificate must show not only that the average is right but that individual strips do not scatter widely around it. USP <905> content uniformity is the reference method, and a strip certificate without a uniformity result is incomplete.

The USP <905> design assays a sample of individual units, computes an acceptance value from the sample mean and standard deviation against the label claim, and compares it with a fixed limit, with a larger second-stage sample if the first stage fails. For films the sources of variation are physical: thickness variation across the cast sheet, uneven distribution of a poorly soluble active in the casting solution, and sectioning error when the sheet is cut. Preis and colleagues' 2013 review in Expert Opinion on Drug Delivery notes that film-specific characterization methods are still not fully harmonized, which is why the certificate should name the method it used.

Loading level changes the analytical difficulty. On a strip such as NAD+ dissolvable strips 100 mg per strip, 30 strips, the active is a large fraction of the film and the assay is straightforward. On Wolverine dissolvable strips, 500 mcg BPC-157 and 300 mcg TB-500 per strip, 30 strips, or CJC-1295 / Ipamorelin dissolvable strips 250 mcg + 250 mcg per strip, 30 strips, the peptides together are well under 2% of a film that weighs tens of milligrams. The laboratory has to extract microgram quantities from a polymer, separate two peptides from each other and from the polymer background, and quantify each against its own reference standard (reading a blend certificate).

What the label and certificate should state

A complete strip label states the mass of each active per strip and the number of strips per pack; a complete certificate pairs each of those claims with a measurement and adds the film-specific tests that a vial certificate never carries. The two documents are read together.

The identity and assay lines deserve a note. A vial certificate reports HPLC purity because the sample is essentially pure peptide. A strip certificate reports assay against label claim, because the dominant component of the extracted sample is polymer, not peptide, and area percent of the whole chromatogram would be meaningless. The purity of the input peptide belongs on the raw-material certificate that precedes the strip (net peptide content versus purity).

How films age

A film's stability is governed by humidity more than by any other factor, because its polymers are hygroscopic and its mechanical and chemical behavior both change with water content. That makes the ICH Q1A(R2) accelerated condition of 40 °C and 75% relative humidity the most informative stress for a strip, and it makes the individual sealed pouch part of the product rather than packaging.

Water uptake plasticizes the film, making it tacky and prone to sticking to its liner; water loss makes it brittle. Plasticizer can migrate to the surface or evaporate over time. Chemically, the bound water in a film is less mobile than bulk solvent, so deamidation, hydrolysis, and oxidation run slower than in a solution of the same peptide but faster than in a lyophilized cake. The gap between those rates is sequence-specific and is established by real-time data, not inferred.

Storage statements for a strip therefore address humidity and light first: sealed in its original pouch, at the labeled temperature, away from moisture. A pouch that has been opened and re-closed is no longer the stability-tested configuration, which is the strip equivalent of a vial whose stopper has been pierced (peptide storage and stability).

Reading a strip against a vial on paper

A strip and a vial of the same peptide can be compared only as masses with different denominators, and the arithmetic is worth doing explicitly. Thirty strips at 250 mcg + 250 mcg contain a nominal 7.5 mg of each peptide across the pack, against 5 mg + 5 mg in a single blend vial; thirty strips at 100 mg of NAD+ contain a nominal 3 g, against 1,000 mg in a vial.

What the arithmetic cannot capture is the matrix. The vial's peptide is accompanied by its counter-ion and a trace of water; the strip's peptide is accompanied by a polymer that outweighs it by a factor of fifty or more, plus plasticizer and bound water. A study that needs the peptide alone starts from the vial. A study of film technology, polymer dissolution, or how a sequence survives casting starts from the strip. The broader comparison of all three formats is in the formats comparison.

Frequently Asked Questions

What are dissolving peptide strips made of?

A water-soluble film-forming polymer such as hypromellose, pullulan, or polyvinyl alcohol, a plasticizer such as glycerol to keep the film flexible, the peptide, and minor taste-masking or coloring agents. The film is cast from a viscous solution onto a liner, dried, and cut into strips, and the polymer accounts for most of each strip's mass.

What does content uniformity mean for a peptide strip?

It is a test that individual strips carry the labeled mass consistently, not just on average. USP <905> content uniformity assays a sample of single strips, calculates an acceptance value from the mean and spread against the label claim, and compares it to a limit. Thickness variation across the cast sheet is the main reason strips can differ.

How should a dissolving strip be stored?

Sealed in its original pouch, at the temperature stated on the label, protected from humidity and light. Film polymers are hygroscopic, so moisture changes the strip's flexibility and can speed chemical degradation of the peptide. An opened pouch no longer matches the configuration that the stability data were generated on.

Why does a strip certificate report assay instead of purity?

Because the sample loaded on the HPLC column is mostly polymer, not peptide, so an area-percent purity of the whole sample would be meaningless. The certificate instead reports each peptide's measured mass per strip as a percentage of the label claim, together with identity by mass spectrometry. The purity of the peptide raw material is reported on its own certificate.

Citations

1. Hoffmann EM, Breitenbach A, Breitkreutz J. Advances in orodispersible films for drug delivery. Expert Opin Drug Deliv. 2011;8(3):299-316. PMID 21284577
2. Preis M, Woertz C, Kleinebudde P, Breitkreutz J. Oromucosal film preparations: classification and characterization methods. Expert Opin Drug Deliv. 2013;10(9):1303-1317. PMID 23768198
3. Borges AF, Silva C, Coelho JF, Simões S. Oral films: Current status and future perspectives: I - Galenical development and quality attributes. J Control Release. 2015;206:1-19. PMID 25747406
4. Dixit RP, Puthli SP. Oral strip technology: overview and future potential. J Control Release. 2009;139(2):94-107. PMID 19559740
5. Visser JC, Woerdenbag HJ, Crediet S, Gerrits E, Lesschen MA, Hinrichs WLJ, Breitkreutz J, Frijlink HW. Orodispersible films in individualized pharmacotherapy: The development of a formulation for pharmacy preparations. Int J Pharm. 2015;478(1):155-163. PMID 25448577
6. Thabet Y, Lunter D, Breitkreutz J. Continuous manufacturing and analytical characterization of fixed-ratio, multilayer orodispersible films. Eur J Pharm Sci. 2018;117:236-244. PMID 29499348
7. Gil MC, Park SJ, Lee BS, Park C, Lee BJ. Dual thermal stabilizing effects of xanthan gums via glycosylation and hydrogen bonding and in vivo human bioavailability of desmopressin in orodispersible film. Int J Pharm. 2023;637:122879. PMID 36958609
8. United States Pharmacopeia. USP <905> content uniformity. USP-NF. current edition. USP-NF
9. International Council for Harmonisation. ICH Q1A(R2): Stability Testing of New Drug Substances and Products. ICH Harmonised Guideline. 2003. ICH Q1A(R2)

This article is for laboratory research reference only. US Prime Peptides products are supplied strictly for in vitro research. Not for human consumption.

Compliance Notice: US Prime Peptides products are supplied strictly for laboratory and academic research purposes only. They are not intended for human or veterinary consumption, diagnosis, treatment, or prevention of any disease. All content on this page is educational in nature and does not constitute medical advice or product claims. Researchers are responsible for handling these compounds in accordance with their institution’s safety protocols and applicable laws.